Strand life Sciences

Based on the comprehensive genomic profiling approach which detects multiple actionable cancer biomarkers at ‘one go’ to optimise…

Oncquest Laboratories has acquired Quest Diagnostic’s Indian facilities from Strand Life Sciences. The acquisition is expected to…

HCG’s partnership with Strand Life Sciences has allowed the hospital to look meticulously at building efficient processes for…

Strand Life Sciences, India, has recently joined the Global Diagnostics Network (GDN). Harish Natarajan, Chief Operating Officer…

The collaboration will help generate enhanced diagnostics insights to improve delivery of global healthcare

In FY 19, the company's revenue is at Rs 9,787 million

As part of this study, 141 unrelated patients and families with breast or ovarian cancer were tested for mutations in 13 genes…

Dr Vijay Chandru, Chairman and CEO, Strand Life Sciences, gives a rundown on the genetic diagnostics market in India, its future…

US team focused on National Launch of StrandAdvantage - company’s pan-cancer genomic profiling service

US team focused on National Launch of StrandAdvantage, company’s pan-cancer genomic profiling service